These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2859970)

  • 21. Cutaneous responses to allergen after local pretreatment with beta-adrenoceptor stimulating and blocking agents.
    Grönneberg R; Strandberg K; Hägermark O
    Allergy; 1980 Jul; 35(5):409-12. PubMed ID: 6108725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prenalterol on renal function in normal man.
    Järnberg PO; Westman L
    Acta Anaesthesiol Scand; 1982 Dec; 26(6):603-6. PubMed ID: 6130667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the stereospecificity of the beta2-adrenoceptor blocking properties of prenalterol.
    Johansson U; Waldeck B
    J Pharm Pharmacol; 1980 Sep; 32(9):659-60. PubMed ID: 6107373
    [No Abstract]   [Full Text] [Related]  

  • 24. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
    Johansson U; Waldeck B
    J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic effects of prenalterol in diabetic patients.
    Oltmanns D
    Acta Med Scand Suppl; 1982; 659():147-55. PubMed ID: 6127885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenoceptor agonist stimulation of pulmonary nitric oxide production in the rabbit.
    Adding LC; Agvald P; Artlich A; Persson MG; Gustafsson LE
    Br J Pharmacol; 1999 Feb; 126(3):833-9. PubMed ID: 10188998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic effects of prenalterol in healthy subjects.
    Johnsson G
    Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of stimulation on the myoelectrical activity of the rectosigmoid in man.
    Taylor I; Duthie HL; Smallwood R; Brown BH; Linkens D
    Gut; 1974 Aug; 15(8):599-607. PubMed ID: 4419566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disodium cromoglycate does not prevent terbutaline-induced desensitization of beta 2-adrenoceptor-mediated cardiovascular in vivo functions in human volunteers.
    Schäfers RF; Piest U; von Birgelen C; Jakubetz J; Daul AE; Philipp T; Brodde OE
    J Cardiovasc Pharmacol; 1999 May; 33(5):822-7. PubMed ID: 10226872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a beta 1-adrenoceptor agonist, prenalterol, on renal function and renin secretion rate in anesthetized dogs.
    Johnson MD; Freese JW; Schmitt DE
    J Cardiovasc Pharmacol; 1984; 6(4):627-33. PubMed ID: 6206317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prenalterol, a beta-1-adrenoceptor agonist, on renin secretion rate in the anaesthetized dog.
    Kopp U; Aurell M; Svensson L; Ablad B
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):230-5. PubMed ID: 6121458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Terbutaline-induced desensitization of beta 2-adrenoceptor in vivo function in humans: attenuation by ketotifen.
    Brodde OE; Petrasch S; Bauch HJ; Daul A; Gnadt M; Oefler D; Michel MC
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):434-9. PubMed ID: 1279289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
    Kenakin TP
    J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta 1- and beta 2-adrenoceptor agonists have different effects on rat parotid acinar cells.
    Henriksson R
    Am J Physiol; 1982 May; 242(5):G481-5. PubMed ID: 6177253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actions of prenalterol, a new cardioselective beta1-agonist, terbutaline and isoprenaline on electrophysiological and mechanical parameters of guinea pig atrial and papillary muscles.
    Arlock P
    Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):12-9. PubMed ID: 6126991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
    Lambertz H; Meyer J; Erbel R
    Circulation; 1984 Feb; 69(2):298-305. PubMed ID: 6140091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.